ID-STROKE V1

  • Research type

    Research Study

  • Full title

    IDentification of Stroke aeTiology to Reduce reOccurrence of stroKe and vascular Events (ID-STROKE)

  • IRAS ID

    352595

  • Contact name

    Clare Gordon

  • Contact email

    cgordon8@uclan.ac.uk

  • Sponsor organisation

    University of Central Lancashire

  • Duration of Study in the UK

    1 years, 1 months, 28 days

  • Research summary

    After a stroke, nearly half of people have another one. If we identify the cause (aetiology) of the first stroke, we are more likely to prevent a second one, saving the NHS and the wider economy millions of pounds. However, almost a third of stroke survivors never have a cause identified, leaving them vulnerable to a secondary stroke. National guidelines for this area of care are unclear, which potentially leads to variability in care, and delays in helpful preventative strategies being put in place.
    This research will explore the variation in clinical practice in stroke aetiology diagnosis and how this impacts stroke survivors and their families. The work will consist of two work packages:

    WP1. A retrospective case note review to determine current practice in stroke aetiology diagnosis; A cohort of consecutive adult patients, admitted from 1st November 2023 to 31st Jan 2024, with acute ischaemic stroke will be selected for review at three NHS stroke services in the Northwest of England. Case finding will continue until 65 consecutive eligible cases have been identified per site. NHS staff at each site will conduct the case note review, entering data directly into a secure REDCap database, following training provided by the research team.

    WP2. Interviews with stroke survivors and their family members/ carers to explore the impact of living with an unknown cause of stroke; up to 30 adult stroke survivors and/ or their family members/carers from the three retrospective case note review sites, will be invited to take part in an interview. Patients who have had an ischemic stroke within the last 3-12 months and who have capacity to take part in an interview and provide consent, will be identified by the clinical teams who will gain permission from the patient to put them in touch with the research team.

  • REC name

    South Central - Berkshire Research Ethics Committee

  • REC reference

    25/SC/0084

  • Date of REC Opinion

    13 Mar 2025

  • REC opinion

    Further Information Favourable Opinion